account_id none on file
legal_name Insulet Corp
ticker PODD
cik 1145197
domain insulet.com
linkedin_company_url https://www.linkedin.com/company/insulet-corporation/
entry_point_account_id none on file
name Insulet Corporation
exchange Nasdaq
sector Health Care
hq Acton, MA, United States
sector index/company/sector/health-care/
calls 0 filings 60 executives 5 family 0
why_nownone on file
callsnone on file
filings
Co-op, Supplier Engineering - Project Management Excellence: January - June 2027 (Onsite) | {"ats": "workday", "city": "Acton", "state": "MA", "job_id": "/job/Acton-Massachusetts/Co-op--Supplier-Engin
company_statement / Sep 16, 2026 / receipt
Clinical Retention Specialist (South - FL, TN, GA, SC) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Miami-Florida/Clinical-Retention-Specialist--South---FL--TN--GA--SC-_REQ-2026-3
company_statement / Sep 16, 2026 / receipt
Continued focus on both T1D globally and the ramping of T2D in the U.S.
ir_statement / Sep 16, 2026 / receipt
Continued investments in R&D to fuel innovation pipeline
ir_statement / Sep 16, 2026 / receipt
Broadened global reach with the Spain launch of Omnipod 5 and Omnipod Discover, marking the 26th country where Insulet sells Omnipod and the 20th country where Omnipod 5 is available
ir_statement / Sep 16, 2026 / receipt
Delivered second-highest new customer start quarter to date, reflecting sequential improvement in the U.S. and continued adoption across international markets
ir_statement / Sep 16, 2026 / receipt
Demonstrated another strong financial quarter with top-line constant currency1 growth of 23% YoY, over 140 bps of adjusted operating margin1 expansion, and 41.5% adjusted EPS1 growth
ir_statement / Sep 16, 2026 / receipt
Category revenue growth accelerated in Q1'26
ir_statement / Sep 16, 2026 / receipt
FY 2026 revenue 20% - 22% (Previously 21% - 23%)
ir_statement / Sep 16, 2026 / receipt
Sr. Analyst, Commercial Insights & Analytics (Hybrid - Acton, MA or San Diego, CA) | {"ats": "workday", "city": "Acton", "state": "MA", "job_id": "/job/Acton-Massachusetts/Sr-Analyst--Commercial-Insig
company_statement / Sep 15, 2026 / receipt
Systems Engineer, Verification & Validation (Hybrid - Acton, MA) | {"ats": "workday", "city": "Acton", "state": "MA", "job_id": "/job/Acton-Massachusetts/Systems-Engineer--Verification---Validation--H
company_statement / Sep 15, 2026 / receipt
Back office analyst (Medical devices) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Guadalajara-Jalisco/Back-office-analyst--Medical-devices-_REQ-2026-18348", "remote": false, "cat
company_statement / Sep 15, 2026 / receipt
executives
| Ashley McEvoy | President and Chief Executive Officer | - | receipt |
| James R. Hollingshead | President and Chief Executive Officer | - | receipt |
| Lauren Budden | Interim Chief Financial Officer | - | receipt |
| Prem Singh | Senior Vice President | - | receipt |
| Wayde D. McMillan | Executive Vice President | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2025-04-28 | President and Chief Executive Officer, appointed | sec_8k |
| 2023-10-03 | Interim Chief Financial Officer, appointed | sec_8k |
| 2022-12-14 | Senior Vice President, appointed | sec_8k |
| 2022-05-06 | President and Chief Executive Officer, appointed | sec_8k |
| 2022-05-06 | President and Chief Executive Officer, departed | sec_8k |
| 2019-04-30 | Vice President, appointed | sec_8k |
| 2019-01-07 | Executive Vice President, appointed | sec_8k |
| 2018-09-14 | Chairman, retiring | sec_8k |
| 2018-09-14 | President and Chief Executive Officer, appointed | sec_8k |
| 2015-06-30 | Chief Operating Officer, departed | sec_8k |
mcp_package_hint
slug insulet-corporation
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$